Curcumin and its analogue (bisdemethoxy curcumin analogue [BDMC-A]) were studied for their possible lipid-lowering properties in carbon tetrachloride (CCl 4 )-induced hepatotoxicity in rats. Carbon tetrachloride (3 ml kg À1 wk À1 ) administration to albino Wistar rats increased the levels of hepatic marker enzymes such as aspartate transaminase (AST), alkaline phosphatase (ALP), and c-glutamyl transferase (GGT) in the plasma. The levels of lipids cholesterol, triglycerides, and free fatty acids were also increased in plasma and tissues (liver, kidney, heart, and brain). Phospholipid levels increased in plasma, heart, and brain but decreased in liver and kidney. Curcumin (80 mg=kg) and BDMC-A (80 mg=kg) administration to CCl 4 -treated rats for a period of 3 months significantly decreased the lipid levels. The effect exerted by BDMC-A was more prominent than that of curcumin. Studies on the histopathology of the liver are also in line with the biochemical parameters studied. These observations show the lipidlowering efficacy of curcumin and its analogue in CCl 4 -induced hepatotoxicity.
Introduction
Carbon tetrachloride (CCl 4 ) is an important model agent to study the pathogenesis of liver injury (Boll et al., 2001) . It is known to cause damage to the liver, lungs, adrenals, and central nervous system in humans and experimental animals (McGregor & Lang, 1996) . CCl 4 requires biotransformation by hepatic microsomal P450 to produce the hepatotoxic metabolite, trichloromethyl radical (CCl 3 ) which, in the presence of oxygen, is further converted to a peroxy radical (CCl 3 OO ). These radicals may interact with membrane lipids leading to peroxidation (Muriel, 1997) . CCl 4 causes an imbalance between the synthesis and degradation of lipids (Boll et al., 2001) .
Curcuma longa Linn. (Zingiberaceae) is a medicinal plant widely cultivated in tropical regions of Asia. Curcumin (diferuloyl methane) (Figure 1 ) is extracted from the rhizomes of Curcuma longa. Curcumin possesses a wide variety of pharmacological properties (Quiles et al., 2002) . The lipid-lowering effect of curcumin in CCl 4 -induced hepatotoxicity (Akila et al., 1998) and in alcohol and polyunsaturated fatty acid-induced hyperlipidemia (Rukkumani et al., 2002) were reported. bisdemethoxycurcumin (BDMC) is a natural curcuminoid that also possess lipid-lowering properties in high fat diet-induced lipid accumulation (Asai & Miyazawa, 2001 ). An analogue of bisdemethoxycurcumin (BDMC-A) ( Figure 2 ) has been reported for its hypolipidemic properties (Rukkumani et al., 2004a) along with its antioxidant (Rukkumani et al., 2004b) and antidiabetic (Anusuya et al., 2003) properties.
There are no available reports on the hypolipidemic properties of BDMC-A in CCl 4 -induced hepatotoxicity. Hence, we made an attempt to study the effect of BDMC-A and to compare it with curcumin on lipid profile in CCl 4 -induced hepatotoxicity in rats.
Materials and Methods

Drugs and chemicals
Curcumin was obtained from Sigma Chemical Company (St. Louis, MO, USA). BDMC-A was synthesised as described by Babu and Rajasekharan (1994) . CCl 4 was purchased from Merck Ltd. (Mumbai, India). All other chemicals and biochemicals used in our study were of high analytical grade.
Experimental animals
Male albino Wistar rats of body weight 150-180 g were obtained from the Central Animal House, Rajah Muthiah Medical College and Hospital, Annamalai University. The rats were housed in polypropylene cages lined with husk. They were fed on a standard pellet diet (Agro Corporation Private Ltd., Bangalore, India), and water was freely available. The standard pellet diet comprised 21% protein, 5% lipids, 4% crude fiber, 8% ash, 1% calcium, 0.6% phosphorus, 3.4% glucose, 2% vitamin, and 55% nitrogen-free extract (carbohydrates). It provides metabolizable energy of 3600 kcal=kg.
Experimental design
A total of 36 rats were used in our study. The rats were divided into 6 groups of 6 rats each.
Group I Normal control rats injected with saline subcutaneously (3 ml=kg body weight per week) and orally administered with saline. Group II Normal rats injected with saline subcutaneously (3 ml=kg body weight per week) and orally administered curcumin (80 mg=kg body weight) (Rukkumani et al., 2002) . Group III Normal rats injected with saline subcutaneously (3 ml=kg body weight per week) and orally administered BDMC-A (80 mg=kg body weight) (Anusuya et al., 2003) . Group IV Rats subcutaneously injected with CCl 4 (3 ml=kg body weight per week) (Akila et al., 1998) and orally administered saline. Group V Rats orally administered curcumin (80 mg=kg body weight) along with subcutaneous injection of CCl 4 (3 ml=kg body weight per week). Group VI Rats orally administered BDMC-A (80 mg=kg body weight) along with subcutaneous injection of CCl 4 (3 ml=kg body weight per week).
The experiment was carried out for a period of 3 months. All the experimental protocols were approved by the Ethical Committee of Annamalai University.
After the last treatment, the animals were fasted overnight and sacrificed by cervical dislocation. Blood was collected in heparinized tubes. Plasma was separated and used for various biochemical estimations. Liver, kidney, heart, and brain were collected in ice-cold containers, washed with saline, homogenized with appropriate buffer, and used for various estimations.
Biochemical estimations
In plasma, the levels of marker enzymes such as AST (aspartate transaminase), ALP (alkaline phosphatase), and GGT (c-glutamyl transferase) were estimated by the methods of Reitman and Frankel (1957) , King and Armstrong (1988) , and Fiala et al. (1972) , respectively.
Lipids were extracted using a chloroform-methanol mixture (2:1 v=v) by the method of Folch et al. (1957) . Total cholesterol (Zlatkis et al., 1953) , triglycerides (Foster & Dunn, 1973) , free fatty acids (Falholt et al., 1973) , and phospholipids (Zilversmit et al., 1950) were estimated in plasma and tissues.
For histopathological studies, livers from animals of different groups were perfused with 10% neutral formalin solution. Paraffin sections were made and stained using hematoxylin-eosin (H&E) stain. After staining, the sections were observed under a light microscope and photographs were taken.
Statistical analysis
Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by Duncan's multiple range test (DMRT). The values are mean AESD for 6 rats in each group. p values < 0.05 were considered as significant.
Results
The effect of oral administration of curcumin and BDMC-A on plasma AST, GGT, and ALP levels in normal and CCl 4 -induced rats is presented in Table 1 . A significant increase in the levels of these marker enzymes was observed in CCl 4 -treated rats. On treatment with both curcumin and BDMC-A, the levels of these enzymes were found to be significantly decreased. Table 2 presents the levels of cholesterol, triglycerides, free fatty acids, and phospholipids in normal and CCl 4 -treated rats in plasma. The levels of these lipids significantly increased in CCl 4 -treated rats. Administration of curcumin and BDMC-A to these rats significantly decreased the lipid levels.
The levels of cholesterol, triglycerides, free fatty acids, and phospholipids in the tissues of normal and CCl 4 -treated rats are presented in Tables 3-6. In CCl 4 -administered rats, the levels of these lipids significantly increased while phospholipids decreased in liver and kidney. Treatment with curcumin and BDMC-A exerted a significant effect on the lipid levels.
In all the parameters studied, administration of curcumin and BDMC-A to normal rats did not show any significant effect. Results obtained with BDMC-A were found to be more effective than those of curcumin.
Discussion
Lipids are more easily attacked by the activated metabolites of CCl 4 resulting in damage to intracellular membranes and the plasma membrane (Cheeseman et al., 1985) . As a result of membrane damage, the levels of marker enzymes such as AST, ALP, and GGT increase in plasma. This increase is mitigated by treatment with curcumin and BDMC-A. Curcumin, by scavenging or neutralizing free radicals, inhibits peroxidation of membrane lipids and maintains cell membrane integrity and their function (Rukkumani et al., 2003) . The presence of hydroxyl group in the ortho position of the aromatic ring in BDMC-A may be responsible for the inhibitory effect (Anto et al., 1996) . The o-hydroxyl group, because of its resonance property, easily donates e À to free radicals and effectively neutralizes them. Curcumin and BDMC-A stabilize cell membrane integrity and prevent the increase of these marker enzymes.
Radical formation and lipid peroxidation are the predominant cellular mechanisms involved in the development of fatty liver caused by CCl 4 (Tribble et al., 1987) . Extensive accumulation of lipids is regarded as a pathological condition, and when the accumulation becomes chronic, fibrotic changes occur in the cells that progress to cirrhosis and impaired liver function (Murray et al., 1993 ). An increase in the levels of cholesterol, triglycerides, and free fatty acids were noted in plasma and tissues. CCl 4 increases the synthesis of fatty acids and triglycerides from acetate. This could be due to the transport of acetate into the liver cell, resulting in increased substrate (acetate) availability. In CCl 4 toxicity, the synthesis of cholesterol is also increased (Boll et al., 2001) .
On the other hand, CCl 4 lowers b-oxidation of fatty acids and hydrolysis of triglycerides. This increases the availability of fatty acids to esterification (Lieber, 2000) . Reports have also shown that during CCl 4 toxicity, fat from the peripheral adipose tissue is translocated to the liver and kidney leading to its accumulation (Devarshi et al., 1986) . Moreover, the synthesis of apolipoproteins is inhibited by CCl 4 (Honma & Suda, 1997) subsequently resulting in the decreased synthesis of lipoproteins. A decrease in the secretion of bile acids is also reported (Boll et al., 2001) .
Phospholipids are the vital components of biomembranes. They are more susceptible to CCl 4 -induced lipid Values are mean AE SD from 6 rats in each group.
Values not sharing a common superscript (a, b, c, d) differ significantly at p < 0.05. Values are mean AE SD from 6 rats in each group.
Values not sharing a common superscript (a, b, c, d ) differ significantly at p < 0.05. peroxidation than other lipid classes (Morrow et al., 1992) . A decrease in the levels of phospholipids in liver and kidney is probably due to an increase in phospholipase activity (Lamb et al., 1988) . During normal lipoprotein metabolism, phospholipids are extensively converted into triglycerides (Wiggins & Gibbons, 1996) . CCl 4 -induced inhibition of lipoprotein-associated triglyceride export may also result in increased release of phospholipids from these tissues. An increase in phospholipid levels in brain and heart could be due to increased phospholipid content of their membranes. Oral administration of curcumin to CCl 4 -treated rats significantly decreased the lipid levels in plasma and tissues. It has been reported that curcumin possesses hypocholesterolemic action and this could be due to a decrease in absorption of cholesterol (Rao et al., 1970) or an increase in HDL cholesterol (Soudamini et al., 1992) . This indicates that curcumin mobilizes excess cholesterol from extrahepatic tissues to liver where it is catabolized. Curcumin also increases the activity of 7a-hydroxylase, which converts cholesterol to bile acids, facilitating the biliary cholesterol excretion (Babu & Srinivasan, 1997) . The decrease in the levels of triglycerides and phospholipids might be due to decreased free fatty acid (FFA) synthesis by curcumin, which may suppress the enzymes involved in FFA synthesis (Rukkumani et al., 2002) .
Treatment with BDMC-A resulted in a significant decrease in the lipid profile in CCl 4 -administered rats. The structure of BDMC-A resembles that of curcumin, and this may have an impact on lipid metabolism. BDMC-A is a potent antioxidant, and the lipid-lowering activity might be due to its antioxidant property. Phenolics have been recognized as a powerful countermeasure against lipid peroxidation (Schroeter et al., 2000) . Phenolic compounds are capable of scavenging free radicals and quenching the lipid peroxidative side chain. Pan et al. (1999) have proposed that hydroxy and hydroperoxy radicals initiate H þ abstraction from a free phenolic substrate to form phenoxy radical that can rearrange to quinone methide radical intermediate, which is excreted via bile. BDMC-A inhibits lipid peroxidation, as well membrane damage and thus prevent the release of free fatty acids. A decrease in the levels of FFA might result in the decreased levels of other lipids.
Histopathological observations of the liver of CCl 4 -administered rats showed thickening of blood vessels ( Figure 6 ). CCl 4 -administered rats when treated with curcumin showed mild sinusoidal dilatation (Figure 7) , and treatment with BDMC-A showed a near normal histology of the liver (Figure 8 ). These observations show the protective effect of both curcumin and BDMC-A in CCl 4 -induced hepatotoxicity in rats. No histological alterations were observed in liver of normal rats and curcumin or BDMC-A treated rats (Figures 3-5) Curcumin and BDMC-A effectively reduced the lipid levels altered by CCl 4 metabolism. The effect exerted by BDMC-A was more pronounced than curcumin. This could be due to the presence of hydroxyl group at the ortho position. Because of its positional isomerism, the ortho hydroxyl group easily donates the e À to the free radicals and effectively neutralizes them. Hence, BDMC-A is more effective than curcumin in treating hyperlipidemia.
